Clinical trial
Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients…
NCT00210184 · Institut Bergonié, Other · Completed
Key facts
| NCT number | NCT00210184 |
|---|---|
| Title | Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer |
| Official title | Multicentric Phase II Trial: Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years Old and More Presenting Gastric Cancer Locally Advanced or Metastatic |
| Acronym | CEPAFIRI |
| Lead sponsor | Institut Bergonié, Other |
| Collaborators | Novartis Industry Sanofi-Synthelabo Aventis Pharmaceuticals |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug |
| Interventions | Irinotecan associated to fluorouracil and leucovorin |
| Enrollment | 42 |
| Start date | Jul 21, 2004 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2010 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 6, 2021 |
| Countries | France |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: